DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Oligomannose Glycopeptide Conjugates Elicit Antibodies Targeting the Glycan Core Rather than Its Extremities

Journal Article · · ACS Central Science
 [1];  [1];  [2];  [1];  [1];  [1];  [3];  [4];  [4]; ORCiD logo [3];  [2]; ORCiD logo [1]
  1. Department of Chemistry, Brandeis University, Waltham, Massachusetts 02454-9110, United States
  2. Department of Integrative Structural and Computational Biology and the Skaggs Institute for Chemical Biology, The Scripps Research Institute, La Jolla, California 92037, United States
  3. Department of Biochemistry, Center for Biomedical Mass Spectrometry, Boston University School of Medicine, Boston, Massachusetts 02215, United States
  4. Department of Surgery, Duke University Medical Center, Durham, North Carolina 27710, United States

Not Available

Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES)
Grant/Contract Number:
AC02-76SF00515
OSTI ID:
1493660
Journal Information:
ACS Central Science, Journal Name: ACS Central Science Journal Issue: 2 Vol. 5; ISSN 2374-7943
Publisher:
American Chemical SocietyCopyright Statement
Country of Publication:
United States
Language:
English

References (72)

A Stepwise Huisgen Cycloaddition Process: Copper(I)-Catalyzed Regioselective “Ligation” of Azides and Terminal Alkynes journal July 2002
SELMA: Selection with Modified Aptamers journal June 2015
Multivalent Glycocluster Design through Directed Evolution journal October 2011
Directed Evolution of 2G12‐Targeted Nonamannose Glycoclusters by SELMA journal November 2013
N-glycan PK Profiling Using a High Sensitivity nanoLCMS Work-Flow with Heavy Stable Isotope Labeled Internal Standard and Application to a Preclinical Study of an IgG1 Biopharmaceutical journal May 2015
Characterization of a soluble class I α-mannosidase in human serum journal April 1999
Structural Evolution of Glycan Recognition by a Family of Potent HIV Antibodies journal September 2014
Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein journal March 2016
Holes in the Glycan Shield of the Native HIV Envelope Are a Target of Trimer-Elicited Neutralizing Antibodies journal August 2016
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates journal February 2017
Defining Criteria for Oligomannose Immunogens for HIV Using Icosahedral Virus Capsid Scaffolds journal April 2010
Synthetic Three-Component HIV-1 V3 Glycopeptide Immunogens Induce Glycan-Dependent Antibody Responses journal December 2017
A Blueprint for HIV Vaccine Discovery journal October 2012
Structural Delineation of a Quaternary, Cleavage-Dependent Epitope at the gp41-gp120 Interface on Intact HIV-1 Env Trimers journal May 2014
Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches journal June 2017
Synthesis of multivalent glycopeptide conjugates that mimic an HIV epitope journal October 2016
Overview of the development and current use of CRM197 conjugate vaccines for pediatric use journal June 2010
Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans journal September 2015
Site-Selective Chemoenzymatic Glycosylation of an HIV-1 Polypeptide Antigen with Two Distinct N-Glycans via an Orthogonal Protecting Group Strategy journal July 2016
Altering the Specificity of the Antibody Response to HIV gp120 with a Glycoconjugate Antigen journal April 2016
Systematic Synthesis and Binding Study of HIV V3 Glycopeptides Reveal the Fine Epitopes of Several Broadly Neutralizing Antibodies journal April 2017
Toward a Carbohydrate-Based HIV-1 Vaccine:  Synthesis and Immunological Studies of Oligomannose-Containing Glycoconjugates journal March 2006
Fully Synthetic Carbohydrate HIV Antigens Designed on the Logic of the 2G12 Antibody journal September 2007
Chemical Synthesis of Highly Congested gp120 V1V2 N -Glycopeptide Antigens for Potential HIV-1-Directed Vaccines journal August 2013
High Temperature SELMA: Evolution of DNA-Supported Oligomannose Clusters Which Are Tightly Recognized by HIV bnAb 2G12 journal January 2014
Directed Evolution of Multivalent Glycopeptides Tightly Recognized by HIV Antibody 2G12 journal February 2014
Unprecedented Role of Hybrid N- Glycans as Ligands for HIV-1 Broadly Neutralizing Antibodies journal March 2018
Broad neutralization coverage of HIV by multiple highly potent antibodies journal September 2011
Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 journal November 2011
Proof of principle for epitope-focused vaccine design journal February 2014
Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies journal June 2013
Recent strategies targeting HIV glycans in vaccine design journal November 2014
Antibody responses to envelope glycoproteins in HIV-1 infection journal May 2015
Dynamics of B cells in germinal centres journal February 2015
Announcing the worldwide Protein Data Bank journal December 2003
Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 journal May 2013
Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 journal May 2013
Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity journal November 2017
Synthetic multivalent V3 glycopeptides display enhanced recognition by glycan-dependent HIV-1 broadly neutralizing antibodies journal January 2017
Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12 journal September 2005
An oligosaccharide-based HIV-1 2G12 mimotope vaccine induces carbohydrate-specific antibodies that fail to neutralize HIV-1 virions journal October 2008
A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity journal September 2010
Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens journal July 2010
Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies journal October 2012
Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer journal January 2013
Recognition of synthetic glycopeptides by HIV-1 broadly neutralizing antibodies and their unmutated ancestors journal October 2013
Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination journal October 2016
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design journal March 2016
The effect of Fc glycan forms on human IgG2 antibody clearance in humans journal November 2008
Antibody recognition of HIV and dengue glycoproteins journal March 2016
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition journal June 2003
A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield journal October 2011
HIV-1 neutralizing antibodies induced by native-like envelope trimers journal June 2015
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen journal March 2016
Mimicry of an HIV broadly neutralizing antibody epitope with a synthetic glycopeptide journal March 2017
A Glycoconjugate Antigen Based on the Recognition Motif of a Broadly Neutralizing Human Immunodeficiency Virus Antibody, 2G12, Is Immunogenic but Elicits Antibodies Unable To Bind to the Self Glycans of gp120 journal April 2008
Antibody 2G12 Recognizes Di-Mannose Equivalently in Domain- and Nondomain-Exchanged Forms but Only Binds the HIV-1 Glycan Shield if Domain Exchanged journal August 2010
Very Few Substitutions in a Germ Line Antibody Are Required To Initiate Significant Domain Exchange journal August 2010
Structure of 2G12 Fab2 in Complex with Soluble and Fully Glycosylated HIV-1 Env by Negative-Stain Single-Particle Electron Microscopy journal June 2014
Yeast-Elicited Cross-Reactive Antibodies to HIV Env Glycans Efficiently Neutralize Virions Expressing Exclusively High-Mannose N-Linked Glycans journal October 2010
Hyperglycosylated Stable Core Immunogens Designed To Present the CD4 Binding Site Are Preferentially Recognized by Broadly Neutralizing Antibodies journal December 2014
Cross-Clade HIV-1 Neutralizing Antibodies Induced with V3-Scaffold Protein Immunogens following Priming with gp120 DNA journal July 2011
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. journal January 1996
Structure and Immune Recognition of the HIV Glycan Shield journal May 2018
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides journal October 2007
The Glycan Shield of HIV Is Predominantly Oligomannose Independently of Production System or Viral Clade journal August 2011
Transplanting Supersites of HIV-1 Vulnerability journal July 2014
Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans journal May 2013
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies journal September 2013
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort journal January 2016
Glycoengineering HIV-1 Env creates ‘supercharged’ and ‘hybrid’ glycans to increase neutralizing antibody potency, breadth and saturation journal May 2018
Production, characterization and pharmacokinetic properties of antibodies with N-linked Mannose-5 glycans journal July 2012